First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Titel:
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
Auteur:
Zhong, Hua Sun, Shengjie Chen, Jianhua Wang, Ziping Zhao, Yanqiu Zhang, Guojun Chen, Gongyan Zhou, Ming Zhou, Jianying Du, Yingying Wu, Lin Xu, Zhi Mei, Xiaodong Zhang, Weidong He, Jingdong Cui, Jiuwei Zhang, Zhihong Luo, Hui Liu, Weiyou Sun, Meili Wu, Jingxun Shen, Yongchun Zhang, Shucai Yang, Nong Wang, Mengzhao Lu, Junguo Li, Kai Yao, Weirong Sun, Qian Yue, Hongmei Wang, Lin Ye, Sheng Li, Bin Zhuang, Xibin Pan, Yueyin Zhang, Min Shu, Yongqian He, Zhiyong Pan, Lei Ling, Yang Liu, Shengming Zhang, Qi Jiao, Shunchang Han, Baohui